BRPI0923513A2 - método e composições para uso de uma vacina de coccidiose - Google Patents

método e composições para uso de uma vacina de coccidiose

Info

Publication number
BRPI0923513A2
BRPI0923513A2 BRPI0923513A BRPI0923513A BRPI0923513A2 BR PI0923513 A2 BRPI0923513 A2 BR PI0923513A2 BR PI0923513 A BRPI0923513 A BR PI0923513A BR PI0923513 A BRPI0923513 A BR PI0923513A BR PI0923513 A2 BRPI0923513 A2 BR PI0923513A2
Authority
BR
Brazil
Prior art keywords
compositions
coccidiosis vaccine
coccidiosis
vaccine
Prior art date
Application number
BRPI0923513A
Other languages
English (en)
Inventor
Michael G Sheppard
Original Assignee
Vectogen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectogen Pty Ltd filed Critical Vectogen Pty Ltd
Publication of BRPI0923513A2 publication Critical patent/BRPI0923513A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0923513A 2008-12-15 2009-12-14 método e composições para uso de uma vacina de coccidiose BRPI0923513A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12259608P 2008-12-15 2008-12-15
PCT/AU2009/001615 WO2010068968A1 (en) 2008-12-15 2009-12-14 Methods and compositions for use of a coccidiosis vaccine

Publications (1)

Publication Number Publication Date
BRPI0923513A2 true BRPI0923513A2 (pt) 2016-01-26

Family

ID=42240825

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923513A BRPI0923513A2 (pt) 2008-12-15 2009-12-14 método e composições para uso de uma vacina de coccidiose

Country Status (16)

Country Link
US (1) US20100150958A1 (pt)
EP (1) EP2376640A1 (pt)
JP (1) JP2013513548A (pt)
KR (1) KR20110132316A (pt)
CN (1) CN102333877A (pt)
AR (1) AR074679A1 (pt)
AU (1) AU2009328621A1 (pt)
BR (1) BRPI0923513A2 (pt)
CA (1) CA2746310A1 (pt)
EA (1) EA201170812A1 (pt)
HR (1) HRP20110484A2 (pt)
IL (1) IL213061A0 (pt)
MX (1) MX2011006409A (pt)
SG (1) SG172184A1 (pt)
TW (1) TW201026322A (pt)
WO (1) WO2010068968A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059298A2 (en) * 2007-11-01 2009-05-07 Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancinc immune responses to eimeria
CA2830305C (en) 2011-03-16 2020-08-25 University Of Guelph Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
EP2922866B1 (en) * 2012-11-21 2019-01-23 Merz Pharma GmbH & Co. KGaA Means and methods for determination of botulinum neurotoxin biological activity
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
CN103251938B (zh) * 2013-04-15 2015-07-15 内蒙古神元生物工程股份有限公司 鸡艾美耳球虫弱毒疫苗产业化生产工艺
EP3145522B1 (en) 2014-05-23 2020-12-23 Phibro Animal Health Corporation Combination, composition, and method of administering the combination or composition to animals
CN104561047A (zh) * 2014-12-18 2015-04-29 扬州大学 毒害艾美耳球虫配子体抗原Engam59基因及其应用
US10285382B2 (en) 2017-01-09 2019-05-14 Synexis Llc Application of dry hydrogen peroxide (DHP) gas to methods of poultry production
USD890898S1 (en) 2018-01-09 2020-07-21 Synexis Llc Device for producing non-hydrated purified hydrogen peroxide gas
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
TWI739358B (zh) * 2019-03-25 2021-09-11 免疫功坊股份有限公司 帶有金屬結合區的複合多肽及其分子構建體
CN112094824B (zh) * 2020-08-19 2021-04-20 湖北省农业科学院畜牧兽医研究所 表达禽腺病毒4型截短Fiber2蛋白的重组新城疫病毒耐热疫苗株及其制备方法与应用
CN112458118B (zh) * 2020-11-25 2022-07-26 吉林大学 新流法腺四联病毒样颗粒及其制备方法和应用
CN113521264A (zh) * 2021-07-14 2021-10-22 中国农业科学院北京畜牧兽医研究所 一种鸽球虫病活疫苗及其制备方法和应用
CN114891120B (zh) * 2022-05-08 2022-12-06 青岛海华生物集团股份有限公司 一种二价禽腺病毒特异性抗原融合蛋白
CN114703153B (zh) * 2022-06-06 2022-08-02 广东省农业科学院动物卫生研究所 一株血清2型禽腺病毒毒株以及疫苗和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68927350T2 (de) * 1988-07-05 1997-04-24 British Tech Group Usa Gentechnologisch hergestellter coccidiose-impfstoff
EP0690912B1 (en) * 1993-04-14 2008-03-05 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
US6296852B1 (en) * 1993-04-14 2001-10-02 Commonwealth Scientific And Industrial Research Organisation Recombinant avian adenovirus vector
DE19615803A1 (de) * 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
US7462707B1 (en) * 2001-07-06 2008-12-09 University Of Technology, Sydney Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of Eimeria maxima and their uses

Also Published As

Publication number Publication date
TW201026322A (en) 2010-07-16
KR20110132316A (ko) 2011-12-07
CN102333877A (zh) 2012-01-25
HRP20110484A2 (hr) 2011-09-30
CA2746310A1 (en) 2010-06-24
MX2011006409A (es) 2011-07-12
EA201170812A1 (ru) 2012-01-30
JP2013513548A (ja) 2013-04-22
EP2376640A1 (en) 2011-10-19
SG172184A1 (en) 2011-07-28
WO2010068968A8 (en) 2010-08-12
AU2009328621A1 (en) 2011-07-07
US20100150958A1 (en) 2010-06-17
WO2010068968A1 (en) 2010-06-24
IL213061A0 (en) 2011-07-31
AR074679A1 (es) 2011-02-02

Similar Documents

Publication Publication Date Title
BRPI0912703A2 (pt) composições imuno-moduladoras e métodos para uso dessas
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BRPI0915928A2 (pt) composições e métodos de uso para anticorpos terapêuticos
BRPI0914300A2 (pt) composições e métodos para imunogenicidade intensificada de somatostatina
BRPI1014316A2 (pt) composição, e, uso de uma composição
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
HUE065114T2 (hu) Monoklórtrifluorpropén vegyületek és készítmények és eljárások azok alkalmazásával
BRPI0916884A2 (pt) composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
BRPI0909780A2 (pt) Composições e métodos para liberação de fármaco
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BRPI1005670A2 (pt) composições adjuvantes e métodos de uso
BRPI0915460A2 (pt) métodos e composições para a liberação intensificada de macromoléculas
BRPI0914069A2 (pt) composição de vacina para uso contra o influenza
BRPI0911685A2 (pt) composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
BR112014014242A2 (pt) método de fortalecimento de fibras de cabelo e uso de uma composição para cabelo
BR112012002102A2 (pt) composição farmaceutica e metodo para preparar uma composição farmaceutica
BRPI0921399A2 (pt) composição de graxa lubrificante, processo para preparar composição lubrificante, e, uso de uma composição de graxa lubrificante
BRPI0918359A2 (pt) composto, composição agroquímica, uso da composição agroquímica e método para preparação do composto
BRPI0914793A2 (pt) Composição, e, uso de uma composição
IL213061A0 (en) Methods and compositions for use of a coccidiosis vaccine
BR112012004173A2 (pt) "composto, composição, método para preparar uma composição, e, uso de um composto"
BRPI0913398A2 (pt) composição e métodos de adesivo para dentaduras
BR112012014028A2 (pt) uso de uma composição
BR112013015085A2 (pt) composição farmacêutica, método para preparar uma composição, e, uso de composição

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]